alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Biopure Corporation for
the period ended January 31, 2003, I, Ronald F. Richards, Chief Financial
Officer, hereby certify, to the best of my knowledge, pursuant to 18 U.S.C.
1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      the Form 10-Q for the period ended January 31, 2003, fully
complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and

         (2)      the information contained in the Form 10-Q for the period
ended January 31, 2003 fairly presents, in all material respects, the financial
condition and results of operations of Biopure Corporation.

/s/ Ronald F. Richards
----------------------

Ronald F. Richards
Chief Financial Officer
March 17, 2003
Exhibit 99.2

[The CIT Group, Inc. Logo]

                                             Contact:  Joan Russo
                                                       Vice President
                                                       Corporate Communications
                                                       (973) 740-5437
                                                       joan.russo@cit.com

FROM: THE CIT GROUP, INC.
      650 CIT DRIVE
      LIVINGSTON, NEW JERSEY 07039

FOR IMMEDIATE RELEASE

             THE CIT GROUP, INC. DECLARES REGULAR QUARTERLY DIVIDEND
             -------------------------------------------------------

      LIVINGSTON, NEW JERSEY, April 27, 2000 --- The Board of Directors of The
CIT Group, Inc. (NYSE:CIT; TSE:CIT.U) declared a regular quarterly cash dividend
of $.10 per common share for shareholders of record on May 10, 2000. The cash
dividend is payable on May 31, 2000.

      CIT is one of the largest commercial and consumer financing companies in
the world. Founded in 1908, the Company (www.cit.com) provides diversified
financing products and services to a broad range of customers through
strategically focused business units.

                                      # # #
# C_2015016EN.01005002.xml

| 19.1.2015 | EN | Official Journal of the European Union | C 16/50 |
| --- | --- | --- | --- |

19.1.2015

EN

Official Journal of the European Union

C 16/50

---

Action brought on 25th November 2014 — ZZ v EMA

(Case F-135/14)

(2015/C 016/75)

Language of the case: English

Parties

Applicant: ZZ (represented by: S. Rodrigues, A. Blot, lawyers)

Defendant: European Medicines Agency (EMA)

Subject-matter and description of the proceedings

The annulment of the decision to assign the applicant on non-active status.

Form of order sought

| — | Annul the decision dated 31 January 2014 of the EMA to place the applicant on non-active status as of 1 February 2014 until the alleged expiry of his contract on 15 March 2014, together with the letter dated 14 March 2014 allegedly intending to ‘clarify’ the reason for placing him on non-active status; |
| --- | --- |

—

Annul the decision dated 31 January 2014 of the EMA to place the applicant on non-active status as of 1 February 2014 until the alleged expiry of his contract on 15 March 2014, together with the letter dated 14 March 2014 allegedly intending to ‘clarify’ the reason for placing him on non-active status;

| — | annul, so far as necessary, the EMA’s decision dated 15 August 2014, rejecting the Applicant’s complaint dated 24 April 2014 against the aforementioned decisions; |
| --- | --- |

—

annul, so far as necessary, the EMA’s decision dated 15 August 2014, rejecting the Applicant’s complaint dated 24 April 2014 against the aforementioned decisions;

| — | repair the moral prejudice suffered by the Applicant estimated at 20 000 euros; |
| --- | --- |

—

repair the moral prejudice suffered by the Applicant estimated at 20 000 euros;

| — | order the EMA to pay all the costs incurred by the Applicant for the present appeal. |
| --- | --- |

—

order the EMA to pay all the costs incurred by the Applicant for the present appeal.

---
|   | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  | November 15, 2010 |   |  By: | /s/ Edward P. Smolyansky                                                                     |   |
|--------|-------------------|--------|-----------|----------------------------------------------------------------------------------------------|--------|
|   |              |   |      | Edward P. SmolyanskyChief Financial and Accounting Officer and Treasurer |   |

----
## IN THE COU RT O F CR IM IN AL AP PE ALS OF TE XAS N O . A P –76, 264 EX PA R TE JESSE BE N A V I D ES , A ppl i c ant ON AP P LI CAT I ON F OR A W RI T OF HABE AS CORP US

FROM BEX AR CO UNTY M E YE RS , J. , f

i l ed a concurri ng and di s s ent i ng opi ni on, i n w hi ch H ERVEY , J. , j oi ne d. CO NC UR RI NG AN D D I S S E NT I NG OP I NI ON T he vi ct i m i n thi s cas e, Penni ngt on, del i ver ed an a ffi davi tt o A ppl i cant ’ s att orney s t at i ng thats he att ended A ppl i cant ’ s r evoca t i on hear i ng and di d notr ecogni ze A ppl i cant as the per s on w ho as s aul t ed her . T hi s l ed A ppl i cantt o fi l e the appl i cat i on forw r i tof habea s corpus thati s befor e us , i n w hi ch he c l ai m s actual i nnocenc e on the bas i s of i dent i ty . Penni ngt on t es t i fi ed atthe habe as hear i ng and aga i n s ai d thatA ppl i cantw as not th e m a n w h o se x u a llya ss a u lted h e r. S h e a lso sa id , fo r th e f irst tim e , tha t sh e c o n se n ted to h a v in g s e x w ith th e p e rs o n w h o d ro v e h e r h o m e f ro m th e a u to s h o p . I c a n se e h o w th e m a

jo rityw o u ld d e n yth e a p p lica tio n o n th e id e n tityiss u e – th e re isBenavides–Pag e 2

c re d ib le e v id e n c e re f

u tin g P e n n in g to n ’s c laim th a t sh e d id n o t re c o g n ize A p p lica n t, i ncl udi ng t es t i m onyfr om A ppl i cant ’ s co- w or kerthatA ppl i canti s the one w ho dr ove Penni ngt on hom e, thatPenni ngt on had pi cked A ppl i cantfr om a phot o l i neup, that A p p lica n t ad m itt e d h e h a d tak e n P e n n in g to n h o m e a n d “ m ig h t h a v e p layed a ro u n d w ith her , ” and thatheri nabi l i tyt o r ecogni ze A ppl i cantatthe r evoca t i on hear i ng w as m any y e a rs a f te r t h e a lle g e d a s s a u lt. T he is sue of

con sent , ho w ever, w as not r ai sed i n the w ri tbefo re us because P e n n i n g t o n ’ s t e s t i mo n yth a ts h e c o n s e n t e d d i d n o to c c u ru n t i l a f t e rth e wr i twa s f

i l e d . At the t i m e of the w r i thear i ng, Penni ngt on’ s cons entoffi ci al l ybeca m e new l ydi s cover ed evi dence . T her efor e, A ppl i canti s ent i t l ed t o fi l e a s epar at e appl i cat i on r ai s i ng the c o n s e n t is s u e . B eca us e cons entw as notr ai s ed i n thi s appl i cat i on forw r i tof habe as corpus , the m aj or i tys houl d noti ncl ude thi s i s s ue i n the dec i s i on t o denythe appl i cat i on. I concur w ith th e d e n ial o f

th e c u rre n t ap p lica tio n o n th e id e n tityiss u e th a t w a s ra ise d , b u t I d isa g re e w ith th e m a

jo rity ’s c o n sid e ra tio n o f th e c o n se n t issu e sin c e it i s n e w ly di s cover ed evi dence thathas noty etbeen r ai s ed i n an appl i cat i on forw r i tof habe as c o rp u s . M ey ers , J.

Fi l ed: M ay26, 2010 D o N ot Pub l i sh
<PAGE>   1
                                                                    EXHIBIT 12.1

                             WEBLINK WIRELESS, INC.
                COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                                 (IN THOUSANDS)
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                                        THREE MONTHS
                                   YEAR ENDED    YEAR ENDED    YEAR ENDED    YEAR ENDED    YEAR ENDED      ENDED      YEAR ENDED
                                  DECEMBER 31,  DECEMBER 31,  DECEMBER 31,  DECEMBER 31   DECEMBER 31,  DECEMBER 31,  DECEMBER 31,
                                      1995          1996          1997         1998 (1)       1999          2000          2000
                                   ---------     ---------     ---------     ---------     ---------     ---------     ---------
<S>                               <C>           <C>           <C>           <C>           <C>           <C>           <C>
Earnings:
  Net loss ....................    $ (53,113)    $ (48,598)    $ (43,887)    $ (59,316)    $ (99,867)    $ (41,636)    $(117,801)
  Add:  Amount of
     previously capitalized
     interest amortized .......           --            --            --           252         2,288           572         2,288
  Add: Fixed charges ..........       30,720        35,041        38,499        43,798        65,310        16,681        65,649
                                   ---------     ---------     ---------     ---------     ---------     ---------     ---------
  Adjusted earnings ...........      (22,393)      (13,557)       (5,388)      (15,266)      (32,269)      (24,383)      (49,864)

Fixed charges:
  Interest in
     indebtedness .............       28,383        32,368        36,672        52,645        63,452        16,070        63,418
  Amortization of debt
     issuance costs ...........        1,052         2,143           844         1,172         1,291           488         1,992
  Interest portion
     of rental and
     lease expense ............        1,285           530           983         1,428           567           123           239
                                   ---------     ---------     ---------     ---------     ---------     ---------     ---------
  Fixed charges ...............       30,720        35,041        38,499        55,245        65,310        16,681        65,649

Deficiency of
  earnings available to
  cover fixed charges .........    $ (53,113)    $ (48,598)    $ (43,887)    $ (70,511)    $ (97,579)    $ (41,064)    $(115,513)
                                   =========     =========     =========     =========     =========     =========     =========

Earnings to fixed charges ratio           --            --            --            --            --            --            --
</TABLE>

(1) The fixed charge adjustment to earnings excludes $11.4 million of
capitalized interest.
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1675 Blood specimen collection device. ( a ) *Identification.* A blood specimen collection device is a device intended for medical purposes to collect and to handle blood specimens and to separate serum from nonserum (cellular) components prior to further testing. This generic type device may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes.
( b ) *Classification.* Class II.
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.5220 Automated differential cell counter. ( a ) *Identification.* An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.
( b ) *Classification.* Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”
[67 FR 1607, Jan. 14, 2002]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Election Assistance Commission

# AGENCY:

U.S. Election Assistance Commission.

# ACTION:

Notice of Public Meeting Agenda.

# Date and Time:

Thursday, March 11, 2010, 10 a.m.-12 p.m. EST.

# Place:

U.S. Election Assistance Commission, 1225 New York Ave, NW., Suite 150, Washington, DC 20005 (Metro Stop: Metro Center).

## Agenda

The Commission will hold a public meeting to discuss identifying and mitigating risk in elections operations. Commissioners will receive an update on re-accrediting Wyle Laboratories, Inc. Commissioners will consider other administrative matters.

Members of the public may observe but not participate in EAC meetings unless this notice provides otherwise. Members of the public may use small electronic audio recording devices to record the proceedings. The use of other recording equipment and cameras requires advance notice to and coordination with the Commission's Communications Office.*

                    * View                     *EAC Regulations Implementing Government in the Sunshine Act*.                

This meeting and hearing will be open to the public.

# Person to Contact for Information:

Bryan Whitener, Telephone: (202) 566-3100.

Thomas R. Wilkey,

Executive Director, U.S. Election Assistance Commission.

[FR Doc. 2010-5052 Filed 3-5-10; 11:15 am]

BILLING CODE 6820-KF-P
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

Nos. 14-13542 & 14-13657

________________________

D.C. Docket No. 8:13-cv-01116-SCB-TGW

WESTERN HERITAGE INSURANCE COMPANY,

Plaintiff - Counter

 Defendant - Appellee

 Cross Appellant,

versus

DENNIS MARK MONTANA, 

a Guardian of Paul N. Blevins, as Assignee of Suncoast Preferred 

Investment Corp., 

REBEKAH J. PATTERSON, as Guardian of minor children,

D.B., D.B., F.B., as Assignee of Suncoast Preferred Investment Corp., 

Defendants - Counter

 Claimants – Counter

Defendants - Appellants

 Cross-Appellees. 

________________________

Nos. 15-10967 & 15-11166

________________________

D.C. Docket No. 8:13-cv-01116-SCB-TGW

Case: 14-13542 Date Filed: 11/23/2015 Page: 1 of 3 
2

WESTERN HERITAGE INSURANCE COMPANY, 

an Arizona corporation,

Plaintiff - Counter

 Defendant - Appellant

 Cross-Appellee,

versus

DENNIS MARK MONTANA, 

as Guardian of Paul N. Blevins, as Assignee of Suncoast Preferred 

Investment Corp., a Florida citizen, 

REBEKAH J. PATTERSON, as Guardian of minor children, 

D.B., D.B., F.B., as Assignee of Suncoast Preferred Investment Corp., 

a Florida citizen,

Defendants - Counter

 Claimants – Counter

Defendants - Appellees 

 Cross-Appellants. 

_______________________

Appeals from the United States District Court

for the Middle District of Florida

________________________

(November 23, 2015)

Before ROSENBAUM, JULIE CARNES, and DUBINA, Circuit Judges.

PER CURIAM: 

We have before us the related appeals and cross-appeals in an insurancecoverage dispute between the Western Heritage Insurance Company (“Western 

Heritage”) and the guardians of Paul Blevins and Blevins’s children (“Blevins”). 

We have carefully reviewed the record and the parties’ briefs, and we have had the 

Case: 14-13542 Date Filed: 11/23/2015 Page: 2 of 3 
3

benefit of oral argument. We now affirm the district court’s orders in all respects 

for the reasons articulated by the district court in its orders.

AFFIRMED.

Case: 14-13542 Date Filed: 11/23/2015 Page: 3 of 3
EXHIBIT 35.1








ANNUAL SERVICER COMPLIANCE STATEMENT PURSUANT TO ITEM 1123 OF REGULATION AB





CARMAX BUSINESS SERVICES, LLC








The undersigned, a duly authorized officer of CarMax Business Services, LLC, as Servicer pursuant to Section 3.10 of the Sale and Servicing Agreement dated as of August 1, 2015 (the "Sale and Servicing Agreement") among CarMax Auto Owner Trust 2015-3, as Issuer (the "Issuer"), CarMax Auto Funding LLC, as Depositor, and CarMax Business Services, LLC, as Servicer (the "Servicer"), does hereby certify that:





|   |                                                                                                              
|-- | -------------------------------------------------------------------------------------------------------------
|1. | CarMax Business Services, LLC is, as of the date hereof, the Servicer under the Sale and Servicing Agreement.




|   |                                                                                      
|-- | -------------------------------------------------------------------------------------
|2. | The undersigned is duly authorized to execute and deliver this Officer's Certificate.




|   |                                                                                                                                                                                                                                                                                                                                                                                                                          
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|3. | A review of the activities of the Servicer during the period beginning onMarch 1, 2016and ending onFebruary 28, 2017and of the Servicer's performance under the Sale and Servicing Agreement was made under my supervision.  To the best of my knowledge, based on such review, the Servicer has fulfilled all of its obligations under the Sale and Servicing Agreement in all material respects throughout such period.







Capitalized terms used in this certificate and not otherwise defined herein have the meanings assigned to them in the Sale and Servicing Agreement.





IN WITNESS WHEREOF, the undersigned, a duly authorized officer of the Servicer, has duly executed this Officer's Certificate this 19th day of May, 2017 .





CARMAX BUSINESS SERVICES, LLC





/s/ Enrique Mayor-Mora


Enrique Mayor-Mora


Vice President and Treasurer
Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant
to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of
The Timberland Company (the "Company"), does hereby certify that to the undersigned's knowledge:



| |  |  | /s/JEFFREY B. SWARTZJeffrey B. Swartz
Chief Executive Officer
| |  |  | -------------------------------------------------------------

Date:
August 11, 2003

The
foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A
signed original of this written statement, required by Section 906, has been provided to The Timberland Company and will be retained by The Timberland Company and furnished to the Securities
and Exchange Commission or its staff upon request.

---

QuickLinks
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3120 Chlamydia serological reagents. ( a ) *Identification.* Chlamydia serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to chlamydia in serum. Additionally, some of these reagents consist of chlamydia antisera conjugated with a fluorescent dye used to identify chlamydia directly from clinical specimens or cultured isolates derived from clinical specimens. The identification aids in the diagnosis of disease caused by bacteria belonging to the genus *Chlamydia* and provides epidemiological information on these diseases. Chlamydia are the causative agents of psittacosis (a form of pneumonia), lymphogranuloma venereum (a venereal disease), and trachoma (a chronic disease of the eye and eyelid).
( b ) *Classification.* Class I (general controls).
# Fourth Court of Appeals

San Antonio, Texas

August 19, 2016

No. 04

- 15

- 00473

- CV

TEXAS DEPARTMENT OF INSURANCE

— Division of Workers’ Compensation and

Commissioner Ryan Brannan, in his official capacity

,

A ppellants

v.

Dale BRUMFIELD

, Appellee

From the 288th Judicial District Court, Bexar County, Texas

Trial Court No. 2015

- CI

- 07374

Honorable Larry Noll, Judge Presiding



### O R D E R

Sitting: Sandee Bryan Marion, Chief Justice

Karen Angelini, Justice

Marialyn Barnard, Justice

Rebeca C. Martinez, Justice

Patricia O. Alvarez, Justice

Luz Elena D. Chapa, Justice

Jason Pulliam, Justice

On August 1, 2016, appellee filed a motion for rehearing en banc. The Court has

considered the motion. Appellee’s motion for rehearing en banc is DENIED

.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 19th day of August, 2016

.

___________________________________ Keith E. Hottle

Clerk of Court